News & AnalysisDepixus lands Series ADepixus, a biotechnology company, has raised 30.6 million euros in Series A financing.ByIris Dorbian15 December 2021•1 min readJavaScript is required to read this article. Please enable it in your browser and reload the page.DealsTechnologyBriefs